| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.39B | 10.30B | 11.42B | 10.18B | 8.96B | 6.73B |
| Gross Profit | 2.59B | 2.70B | 2.64B | 2.40B | 1.86B | 1.96B |
| EBITDA | 2.78B | 2.71B | 2.92B | 2.61B | 2.20B | 1.52B |
| Net Income | 1.28B | 859.55M | 945.72M | 733.21M | 499.59M | 587.76M |
Balance Sheet | ||||||
| Total Assets | 43.01B | 41.95B | 43.53B | 41.85B | 42.90B | 39.13B |
| Cash, Cash Equivalents and Short-Term Investments | 3.91B | 3.95B | 3.64B | 2.99B | 2.59B | 1.82B |
| Total Debt | 12.34B | 12.88B | 14.00B | 15.07B | 16.75B | 14.80B |
| Total Liabilities | 21.19B | 21.82B | 23.97B | 23.67B | 25.41B | 22.52B |
| Stockholders Equity | 19.36B | 17.74B | 17.20B | 15.97B | 15.33B | 14.51B |
Cash Flow | ||||||
| Free Cash Flow | 1.20B | 1.95B | 1.94B | 1.93B | -1.06B | -10.07B |
| Operating Cash Flow | 2.43B | 2.37B | 2.27B | 2.30B | 2.04B | 2.14B |
| Investing Cash Flow | -1.24B | -627.31M | -165.85M | -147.64M | -2.98B | -12.14B |
| Financing Cash Flow | -1.10B | -1.48B | -1.37B | -1.90B | 1.74B | 10.07B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥196.10B | 13.54 | 10.24% | 2.43% | 6.08% | 8.55% | |
75 Outperform | ¥120.03B | 24.35 | ― | 1.79% | 10.76% | 54.82% | |
72 Outperform | ¥8.94B | 7.11 | ― | 2.75% | -4.76% | 8.43% | |
66 Neutral | ¥154.04B | 48.89 | 2.34% | 3.38% | >-0.01% | -49.83% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | ¥238.39B | 19.95 | 5.31% | 2.29% | -6.04% | 146.54% |